Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients

Hepatology Research

Volumn 40, Issue 10, 2010, Pages 997-1005

  Takahashi, Hirokazu ^a   Mizuta, Toshihiko ^a   Kawazoe, Seiji ^b   Eguchi, Yuichiro ^a   Kawaguchi, Yasunori ^a   Otuka, Taiga ^b   Oeda, Satoshi ^b   Ario, Keisuke ^b   Iwane, Shinji ^a   Akiyama, Takumi ^b   Ozaki, Iwata ^a   Fujimoto, Kazuma ^a  

^a SAGA UNIVERSITY   (Japan)

^b Saga Prefectural Hospital   (Japan)

Author keywords

Elderly patients; Hepatocellular carcinoma; Radiofrequency ablation; Survival rate

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; GAMMA GLUTAMYLTRANSFERASE;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; SURVIVAL RATE;

EID: 77957245589     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00713.x     Document Type: Article

References (30)

1. Bosetti C, Levi F, Boffetta P. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 2008, 48:137-45.
2. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004, 127:S27-34.
3. Kiyosawa K, Umemura T, Ichijo T. Hepatocellular carcinoma: recent trend in Japan. Gastroenterology 2004, 127:S17-26.
4. Umemura T, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res 2007, 37:S95-100.
5. Ikai I, Arii S, Okazaki M. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 2007, 37:676-91.
6. Taura N, Hamasaki K, Nakao K. Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in Japan. Oncol Rep 2006, 16:837-43.
7. Hasegawa K, Makuuchi M, Takayama T. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008, 49:589-94.
8. Fan ST, Ng IO, Poon RT. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg 1999, 134:1124-30.
9. Mazzaferro V, Regalia E, Doci R. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693-9.
10. Rossi S, Di Stasi M, Buscarini E. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996, 167:759-68.
11. Allgaier HP, Deibert P, Zuber I. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 1999, 353:1676-7.
12. Curley SA, Izzo F, Ellis LM. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000, 232:381-91.
13. Cho YK, Kim JK, Kim MY. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009, 49:453-9.
14. Colapinto ND. Is age alone a contraindication to major cancer surgery? Can J Surg 1985, 28:323-6.
15. Barlow AP, Zarifa Z, Shillito RG. Surgery in a geriatric population. Ann R Coll Surg Engl 1989, 71:110-14.
16. Vital Statistics Japan (1995-2008). http://ganjoho.jp/professional/statistics/statistics.html, Ministry of Health, Labor and Welfare, Cited 5 Aug 2010.] Available from URL:
17. Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2009, 39:850-8. The Japan Cancer Surveillance Research Group
18. Greene FL, Page DL, Fleming ID. AJCC Cancer Staging Manual 2002, 131-44. 6th ed, edn., Chicago, USA, Springer
19. Catalano O, Esposito M, Nunziata A. Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma. Abdom Imaging 2000, 25:607-14.
20. Goldberg SN, Charboneau JW, Dodd GD. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003, 228:335-45.
21. Poon RT, Fan ST, Lo CM. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 1999, 94:2460-6.
22. Ferrero A, Viganò L, Polastri R. Hepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patients. World J Surg 2005, 29:1101-5.
23. Oishi K, Itamoto T, Kobayashi T. Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more. J Gastrointest Surg 2009, 13:695-701.
24. Kondo K, Chijiiwa K, Funagayama M. Hepatic resection is justified for elderly patients with hepatocellular carcinoma. World J Surg 2008, 32:2223-9.
25. Tateishi R, Shiina S, Teratani T. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005, 06:1201-8.
26. Ishiguro S, Inoue M, Tanaka Y. Serum aminotransferase level and risk of hepatocellular carcinoma: a population-based cohort study in Japan. Eur J Cancer Prev 2009, 18:26-32.
27. Greenwel P, Domínguez-Rosales JA, Mavi G. Hydrogen peroxide: a link between acetaldehyde-elicited alpha1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells. Hepatology 2000, 31:109-16.
28. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001, 38:263-355.
29. Shimizu I, Inoue H, Yano M. Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection. Liver 2001, 21:342-9.
30. Villa E, Dugani A, Moles A. Variant liver estrogen receptor transcript already occur at an early stage of chronic liver disease. Hepatology 1998, 27:983-9.